The cross-sectional study of hospitalized COVID-19 patients in Xiangyang, Hubei province
Objective To study the epidemiological and clinical characteristics of the Corona Virus Disease 2019 (COVID-19) hospitalized patients in Xiangyang No.1 people’s hospital, to offer suggestions to the urgent needs of COVID-19 prevention, diagnosis and treatment.Methods In this study, all the confirmed...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of New Medicine
2020-10-01
|
| Series: | Yixue xinzhi zazhi |
| Subjects: | |
| Online Access: | https://yxxz.whuznhmedj.com/storage/attach/2010/HLkLFPy4MIQdJownEPYy0NxMpBI20J6soM6U0GLf.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846107009633484800 |
|---|---|
| author | Jin-Wei AI Yong WANG Jun-Wen CHEN Xiao-Yun LIU Wu-Feng FAN Guo-Xin HUANG Gao-Jing QU Mei-Ling ZHANG Sheng-Duo PEI Yang LI Li-Sha WANG Bin PEI |
| author_facet | Jin-Wei AI Yong WANG Jun-Wen CHEN Xiao-Yun LIU Wu-Feng FAN Guo-Xin HUANG Gao-Jing QU Mei-Ling ZHANG Sheng-Duo PEI Yang LI Li-Sha WANG Bin PEI |
| author_sort | Jin-Wei AI |
| collection | DOAJ |
| description | Objective To study the epidemiological and clinical characteristics of the Corona Virus Disease 2019 (COVID-19) hospitalized patients in Xiangyang No.1 people’s hospital, to offer suggestions to the urgent needs of COVID-19 prevention, diagnosis and treatment.Methods In this study, all the confirmed cases in Xiangyang No.1 people’s hospital were included until Feb 9, 2020. After all data were extracted and analyzed, we summarized the COVID-19 patients epidemiological and clinical features.Results 102 cases were confirmed by real-time RT-PCR, including 52 males and 50 females with an average age of 50.38 years (SD 16.86). We found 7 imported cases and 37 patients with travel history to Wuhan while rest are secondary cases such as family clustered infections. Incubation time of COVID-19 ranges from 1 day up to 20 days, average period was 8.09 days (SD 4.99). Fever (84%), cough (57%), fatigue (27%), shortness of breath (23%), diarrhea (15%), expectoration (12%), inappetence (10%) were the most common clinical manifestations. According to the laboratory findings, 21 patients showed decreased blood leukocyte count and lymphopenia was observed in 56 patients. 66 (66/97) patients showed elevated C-reactive protein level, 49 (49/85) patients had increased erythrocytes sedimentation rate. Higher level of procalcitonin and ferritin were observed in 19 (19/72) and 12 (12/13) patients, respectively. Anti-viral and anti-inflammatory treatments were taken on all patients according to their symptoms. Among all hospitalized patients, 8 were admitted to intensive care unit (ICU), 6 developed respiratory failure and 3 had multiple organ failure. 3 death were recorded by Feb 10, 2020. 90 patients were found with typical radiological findings of pneumonia on chest computed tomography (CT) for first examination and this number increased to 100 in second CT scan as a consistency of 98% with rea-time RT-PCR diagnosis. When retrospected to the first real-time RT-PCR examination, which showed 66% positive rate while the following second and third test showed 86% and 96% cumulative positive rate among all included patients, respectively.Conclusions Most COVID-19 patients in Xiangyang were identified as secondary cases, some cases had long incubation period, no significant difference of susceptibility was found between genders, middle-to-old-age population were sensitive to SARS-CoV-2 infection, severe and fatal cases mainly came from patients over 70 years old. For the mentioned phenomenon, special interventions need to be taken. Some parameters like ferritin could be used as possible clinical markers of COVID-19 associated inflammation. The low rate of severe cases and low mortality could be due to active prevention after the outbreak and relative adequate access to medical resources. Repeated real-time RT-PCR for 3 times together with 2 times of CT scans and symptoms could give significantly higher positive rate than single examination, benefits the COVID-19 prevention, diagnosis and treatment. |
| format | Article |
| id | doaj-art-abe7af3fbcd4486589e36d2b72b953d7 |
| institution | Kabale University |
| issn | 1004-5511 |
| language | zho |
| publishDate | 2020-10-01 |
| publisher | Editorial Office of New Medicine |
| record_format | Article |
| series | Yixue xinzhi zazhi |
| spelling | doaj-art-abe7af3fbcd4486589e36d2b72b953d72024-12-27T02:43:06ZzhoEditorial Office of New MedicineYixue xinzhi zazhi1004-55112020-10-0130535536310.12173/j.issn.1004-5511.2020.05.046182The cross-sectional study of hospitalized COVID-19 patients in Xiangyang, Hubei provinceJin-Wei AIYong WANGJun-Wen CHENXiao-Yun LIUWu-Feng FANGuo-Xin HUANGGao-Jing QUMei-Ling ZHANGSheng-Duo PEIYang LILi-Sha WANGBin PEIObjective To study the epidemiological and clinical characteristics of the Corona Virus Disease 2019 (COVID-19) hospitalized patients in Xiangyang No.1 people’s hospital, to offer suggestions to the urgent needs of COVID-19 prevention, diagnosis and treatment.Methods In this study, all the confirmed cases in Xiangyang No.1 people’s hospital were included until Feb 9, 2020. After all data were extracted and analyzed, we summarized the COVID-19 patients epidemiological and clinical features.Results 102 cases were confirmed by real-time RT-PCR, including 52 males and 50 females with an average age of 50.38 years (SD 16.86). We found 7 imported cases and 37 patients with travel history to Wuhan while rest are secondary cases such as family clustered infections. Incubation time of COVID-19 ranges from 1 day up to 20 days, average period was 8.09 days (SD 4.99). Fever (84%), cough (57%), fatigue (27%), shortness of breath (23%), diarrhea (15%), expectoration (12%), inappetence (10%) were the most common clinical manifestations. According to the laboratory findings, 21 patients showed decreased blood leukocyte count and lymphopenia was observed in 56 patients. 66 (66/97) patients showed elevated C-reactive protein level, 49 (49/85) patients had increased erythrocytes sedimentation rate. Higher level of procalcitonin and ferritin were observed in 19 (19/72) and 12 (12/13) patients, respectively. Anti-viral and anti-inflammatory treatments were taken on all patients according to their symptoms. Among all hospitalized patients, 8 were admitted to intensive care unit (ICU), 6 developed respiratory failure and 3 had multiple organ failure. 3 death were recorded by Feb 10, 2020. 90 patients were found with typical radiological findings of pneumonia on chest computed tomography (CT) for first examination and this number increased to 100 in second CT scan as a consistency of 98% with rea-time RT-PCR diagnosis. When retrospected to the first real-time RT-PCR examination, which showed 66% positive rate while the following second and third test showed 86% and 96% cumulative positive rate among all included patients, respectively.Conclusions Most COVID-19 patients in Xiangyang were identified as secondary cases, some cases had long incubation period, no significant difference of susceptibility was found between genders, middle-to-old-age population were sensitive to SARS-CoV-2 infection, severe and fatal cases mainly came from patients over 70 years old. For the mentioned phenomenon, special interventions need to be taken. Some parameters like ferritin could be used as possible clinical markers of COVID-19 associated inflammation. The low rate of severe cases and low mortality could be due to active prevention after the outbreak and relative adequate access to medical resources. Repeated real-time RT-PCR for 3 times together with 2 times of CT scans and symptoms could give significantly higher positive rate than single examination, benefits the COVID-19 prevention, diagnosis and treatment.https://yxxz.whuznhmedj.com/storage/attach/2010/HLkLFPy4MIQdJownEPYy0NxMpBI20J6soM6U0GLf.pdfsars-cov-2 covid-19 cross-sectional study |
| spellingShingle | Jin-Wei AI Yong WANG Jun-Wen CHEN Xiao-Yun LIU Wu-Feng FAN Guo-Xin HUANG Gao-Jing QU Mei-Ling ZHANG Sheng-Duo PEI Yang LI Li-Sha WANG Bin PEI The cross-sectional study of hospitalized COVID-19 patients in Xiangyang, Hubei province Yixue xinzhi zazhi sars-cov-2 covid-19 cross-sectional study |
| title | The cross-sectional study of hospitalized COVID-19 patients in Xiangyang, Hubei province |
| title_full | The cross-sectional study of hospitalized COVID-19 patients in Xiangyang, Hubei province |
| title_fullStr | The cross-sectional study of hospitalized COVID-19 patients in Xiangyang, Hubei province |
| title_full_unstemmed | The cross-sectional study of hospitalized COVID-19 patients in Xiangyang, Hubei province |
| title_short | The cross-sectional study of hospitalized COVID-19 patients in Xiangyang, Hubei province |
| title_sort | cross sectional study of hospitalized covid 19 patients in xiangyang hubei province |
| topic | sars-cov-2 covid-19 cross-sectional study |
| url | https://yxxz.whuznhmedj.com/storage/attach/2010/HLkLFPy4MIQdJownEPYy0NxMpBI20J6soM6U0GLf.pdf |
| work_keys_str_mv | AT jinweiai thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT yongwang thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT junwenchen thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT xiaoyunliu thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT wufengfan thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT guoxinhuang thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT gaojingqu thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT meilingzhang thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT shengduopei thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT yangli thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT lishawang thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT binpei thecrosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT jinweiai crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT yongwang crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT junwenchen crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT xiaoyunliu crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT wufengfan crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT guoxinhuang crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT gaojingqu crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT meilingzhang crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT shengduopei crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT yangli crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT lishawang crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince AT binpei crosssectionalstudyofhospitalizedcovid19patientsinxiangyanghubeiprovince |